Inoda, Satoko <br/><br/>
The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.  [electronic resource] 

 -  Experimental and molecular pathology  Feb 2011 
 - 55-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0945 
<br/><br/><label>Standard No.: </label>10.1016/j.yexmp.2010.10.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cancer Vaccines--therapeutic use<br/>Cell Cycle Proteins--immunology<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--immunology<br/>Feasibility Studies<br/>Female<br/>HLA-A Antigens--immunology<br/>HLA-A24 Antigen<br/>Humans<br/>Nuclear Proteins--immunology<br/>Peptides--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Vaccines, Subunit--immunology